MiRNA-based therapy for Gastric Cancer: Tumor suppressor p33(ING1b) suppresses the expression of ERBB2 via up regulation of its target gene , 15/June/2014, 8.17 am

MiRNA-based therapy for Gastric Cancer: Tumor suppressor p33(ING1b) suppresses the expression of ERBB2 via up regulation of its target gene , 15/June/2014, 8.17 am

MiRNA-based therapy for Gastric Cancer: Tumor suppressor p33(ING1b) suppresses the expression of ERBB2 via up regulation of its target gene , 15/June/2014, 8.17 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, MiRNA-based therapy for Gastric Cancer: Tumor suppressor p33(ING1b) suppresses the expression of ERBB2 via up regulation of its target gene , 15/June/2014, 8.17 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Share
Start Typing